HomeBMT • ASX
add
Beamtree Holdings Ltd
Previous close
$0.28
Day range
$0.26 - $0.28
Year range
$0.17 - $0.38
Market cap
70.94M AUD
Avg Volume
229.09K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 7.33M | 19.44% |
Operating expense | 2.66M | 30.16% |
Net income | -1.10M | 20.78% |
Net profit margin | -15.04 | 33.69% |
Earnings per share | — | — |
EBITDA | -822.00K | 17.30% |
Effective tax rate | 7.97% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.30M | -33.90% |
Total assets | 59.65M | -4.60% |
Total liabilities | 12.52M | -18.23% |
Total equity | 47.14M | — |
Shares outstanding | 288.98M | — |
Price to book | 1.72 | — |
Return on assets | -5.13% | — |
Return on capital | -6.27% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -1.10M | 20.78% |
Cash from operations | 905.50K | 618.65% |
Cash from investing | -1.03M | -49.82% |
Cash from financing | 91.00K | -95.96% |
Net change in cash | -29.00K | -101.71% |
Free cash flow | -35.31K | 87.78% |
About
Beamtree is a health data analytics company based in Sydney, Australia. Tim Kelsey was appointed chief executive in December 2020. Mark Britnell was appointed chair of the Beamtree Global Impact Committee in August 2021.
An international division was launched in the UK in 2021. The company funds an Associate Professor of Clinical Informatics and Data Science at the University of Sydney. Wikipedia
CEO
Founded
1996
Website
Employees
97
